602 filings
Page 2 of 31
UPLOAD
4cip51rs3cxa3kuev0
19 May 23
Letter from SEC
12:00am
8-K
g98wuqrw0
2 May 23
Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results
4:09pm
CORRESP
2pwv2
18 Apr 23
Correspondence with SEC
12:00am
UPLOAD
zu4gvb o5
4 Apr 23
Letter from SEC
12:00am
S-8
9l2rv
23 Mar 23
Registration of securities for employees
1:41pm
8-K
w0rgz1gyqu cj
20 Mar 23
Submission of Matters to a Vote of Security Holders
5:48pm
CORRESP
35r6qer
3 Mar 23
Correspondence with SEC
12:00am
8-K
tiwr4
15 Feb 23
Termination of a Material Definitive Agreement
8:34am
8-K
g4hvbzmk34qo0i huabd
14 Feb 23
Departure of Directors or Certain Officers
5:18pm
UPLOAD
dzhutmlfw3ydl4
10 Feb 23
Letter from SEC
12:00am
8-K
z2vtoxqi8b6mjtf35im
7 Feb 23
Other Events
8:41pm
8-K
e01x3z3s0wf
6 Feb 23
Arrowhead Pharmaceuticals Reports Fiscal 2023 First Quarter Results
4:02pm
8-K
a2iifq77 goy2dq12a44
30 Jan 23
Amendments to Articles of Incorporation or Bylaws
5:15pm
8-K
sjkka2
8 Dec 22
Entry into a Material Definitive Agreement
4:46pm
S-3ASR
yfczsx8s
2 Dec 22
Automatic shelf registration
9:23pm
8-K
wj4bm
28 Nov 22
Arrowhead Pharmaceuticals Reports Fiscal 2022 Third Quarter Results
4:06pm